Active Shortage Injection Oncology

Carboplatin Injection · 1,232 days since initial FDA posting

Brand: CARBOPLATIN

FDA lists Carboplatin Injection as Active Shortage (Gland Pharma Limited).

Availability on file: Limited Availability

Carboplatin Injection: Active Shortage

Limited Availability Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Carboplatin Injection
Manufacturer
Gland Pharma Limited
Dosage Form
Injection
Presentation
Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01)
Package NDC
54288-167-01

Status & Timeline

Status
Active Shortage
Availability
Limited Availability
First Reported
Apr 28, 2023
Last Updated
Sep 29, 2025
Therapeutic Category
Oncology

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Estimated recovery: Q4 2025; Distributed by BPI Labs, LLC

Nearby, Other Carboplatin Shortage Records

Carboplatin Injection

Gland Pharma Limited

Injection

Active Shortage

Carboplatin Injection

Gland Pharma Limited

Injection

Active Shortage

Carboplatin Injection

Gland Pharma Limited

Injection

Active Shortage

Carboplatin Injection

Teyro Labs

Injection

Active Shortage

Carboplatin Injection

Teyro Labs

Injection

Active Shortage

Carboplatin Injection

Teyro Labs

Injection

Active Shortage

FDA reason on file: Estimated recovery: Q4 2025; Distributed by BPI Labs, LLC. General shortage guidance lives on the tracker hub.

← All Drug Shortages